Does Merck have a “homefield advantage” in the next Vioxx trial?
“In Texas, there’s significant bias against what’s considered an out-of-town evil drug company. But in New Jersey, you actually know people who work at Merck and Pfizer, so it puts a human face on it. It’s not big, bad pharma; it’s my neighbor Joe.”
Does Merck have a “homefield advantage” in the next Vioxx trial?
Real physician voices, twice a week
Free, and one click to unsubscribe.
